AstraZeneca PLC Capital Reinvestment Ratio
AstraZeneca PLC capital reinvestment ratio. AstraZeneca PLC (ZEGA) has a Capital Reinvestment Ratio of 0.34x as of September 2025, meaning it reinvests 0% of its operating cash flow (€5.13 Billion) in capital expenditures (€1.73 Billion). Check AstraZeneca PLC cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of AstraZeneca PLC (2014–2024)
Capital reinvestment ratio of AstraZeneca PLC from 2014 to 2024. This chart tracks AstraZeneca PLC's Capital Reinvestment Ratio across 11 annual periods. Also explore ZEGA net assets growth trend to track the company's year-over-year net asset growth rate.
AstraZeneca PLC Capital Reinvestment Ratio by Year (2014–2024)
AstraZeneca PLC capital reinvestment ratio by year from 2014 to 2024. For the full cash flow conversion analysis, see AstraZeneca PLC cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.39x | €11.86 Billion | €4.59 Billion | ▲ +18.3% |
| 2023 | 0.33x | €10.36 Billion | €3.39 Billion | ▲ +193.7% |
| 2022 | 0.11x | €9.81 Billion | €1.09 Billion | ▼ -39.2% |
| 2021 | 0.18x | €5.96 Billion | €1.09 Billion | ▼ -8.6% |
| 2020 | 0.20x | €4.80 Billion | €961.00 Million | ▼ -39.3% |
| 2019 | 0.33x | €2.97 Billion | €979.00 Million | ▼ -17.2% |
| 2018 | 0.40x | €2.62 Billion | €1.04 Billion | ▲ +7.5% |
| 2017 | 0.37x | €3.58 Billion | €1.33 Billion | ▼ -33.6% |
| 2016 | 0.56x | €4.14 Billion | €2.31 Billion | ▲ +39.7% |
| 2015 | 0.40x | €3.32 Billion | €1.33 Billion | ▲ +178.6% |
| 2014 | 0.14x | €7.06 Billion | €1.01 Billion | — |